Search IVDmap

Search products, companies, tests, and guides — go from query to quote request in one place.

Article

Optimization of PCR amplification and sequencing of GC-rich protein-coding region of CEBPA (CCAAT/enhancer binding protein alpha) in acute myeloid leukemia patients using betaine.

Research record from Mol Biol Rep, 2026-07-15. PMID 42455225.

Indicators

PDGFRB Gene

This gene plays a role in mitogenic activities affecting mesenchymal cells and a translocation in the gene results in chronic myelomonocytic leukemia.

Article

Pediatric Acute Leukemias: Epidemiological, Clinical Features, and Diagnostic Contribution of Flow Cytometry in a Resource-Limited Setting.

Research record from Cureus, 2026-07-30. PMID 42668927.

Article

Prospective feasibility study of peripheral blood for MRD detection in acute myeloid leukemia by flow cytometry.

Research record from Blood Adv, 2026-04-01. PMID 41649796.

Indicators

RAF1 Gene

This gene is involved in cell growth, proliferation, differentiation and migration. It also plays a role in apoptosis.

Article

Rapid Molecular Diagnostics Enables Individualized Frontline Treatment of CBFA2T3::GLIS2-Rearranged Acute Myeloid Leukemia.

Research record from Pediatr Blood Cancer, 2026-07-25. PMID 42500906.

Indicators

RUNX1 Gene

This gene plays a role in transcriptional regulation and cytogenetic aberrations are associated with several leukemias.

Article

Spectrum of actionable genetic variants in acute myeloid leukaemia patients from Pakistan: a study based on next-generation sequencing.

Research record from Ecancermedicalscience, 2026-05-27. PMID 42428814.

Indicators

Tumor-associated oncofetal glycoprotein 72 (TAG-72) is a high molecular weight (220-400 kD) complex expressed by a wide variety of human adenocarcinomas. This antigen is expressed by a majority of invasive ductal breast carcinomas, and most colon, pancreatic, gastric, esophageal, lung (non-small cell), ovarian and endometrial adenocarcinomas, and on normal secretory endometrium, but not on other normal tissues. It is not expressed by leukemias, lymphomas, sarcomas, mesotheliomas, melanomas or benign tumors. The monoclonal antibodies against TAG-72 have been widely employed for the immunohistochemical analysis of adenocarcinomas as well as for radioimmunoscintigraphy and radioimmunoguided surgery.

Article

Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications.

Research record from Leukemia, 2026-04-08. PMID 41951940.

Article

The Application Value of Flow Cytometry-Based Peripheral Blood Leukocyte Classification in Screening for Acute Leukemia and Posttreatment Monitoring.

Research record from J Clin Lab Anal, 2026-03-18. PMID 41848210.

Article

Ultra-high-sensitivity next-generation sequencing-based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort.

Research record from Blood Cancer J, 2026-05-28. PMID 42209455.

Loading

Search IVDmap

Optimization of PCR amplification and sequencing of GC-rich protein-coding region of CEBPA (CCAAT/enhancer binding protein alpha) in acute myeloid leukemia patients using betaine.

PDGFRB Gene

Pediatric Acute Leukemias: Epidemiological, Clinical Features, and Diagnostic Contribution of Flow Cytometry in a Resource-Limited Setting.

Prospective feasibility study of peripheral blood for MRD detection in acute myeloid leukemia by flow cytometry.

RAF1 Gene

Rapid Molecular Diagnostics Enables Individualized Frontline Treatment of CBFA2T3::GLIS2-Rearranged Acute Myeloid Leukemia.

RUNX1 Gene

Spectrum of actionable genetic variants in acute myeloid leukaemia patients from Pakistan: a study based on next-generation sequencing.

TAG-72 Antigen

Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications.

The Application Value of Flow Cytometry-Based Peripheral Blood Leukocyte Classification in Screening for Acute Leukemia and Posttreatment Monitoring.

Ultra-high-sensitivity next-generation sequencing-based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort.